Results 11 to 20 of about 3,921,277 (285)

Batch Crystallization of Active Pharmaceutical Ingredient: Kinetics and Equilibrium Modelling [PDF]

Kemija u Industriji, 2018
Development of a mathematical model for batch crystallization of fesoterodine fumarate, an active pharmaceutical ingredient, in 2-butanone is presented.
Marko Trampuž, Dušan Teslić, Blaž Likozar   +2 more
doaj   +3 more sources

THE PROCEDURE OF ACTIVE PHARMACEUTICAL INGREDIENT SUPPLIERS PRELIMINARY CHOICE FOR MEDICINE MANUFACTURE [PDF]

Разработка и регистрация лекарственных средств, 2019
The paper demonstrates application of the newly developed procedure for pre-selection of suppliers of active pharmaceutical ingredient to manufacture of drugs using the tools of risk analysis.
S. A. Zaitsev, A. V. Basevich, A. O. Hrustaleva   +2 more
doaj   +1 more source

Structure of the active pharmaceutical ingredient bismuth subsalicylate [PDF]

, 2021
Structure determination of pharmaceutical compounds is invaluable for drug development but is challenging for those that form as small crystals with defects.
A. Ken, Inge, Mathias, Nero, Tom, Willhammar, Erik, Svensson Grape, Victoria, Rooth   +4 more
core   +2 more sources

Ionic Liquids as Active Pharmaceutical Ingredients [PDF]

ChemMedChem, 2011
AbstractIonic liquids (ILs) are ionic compounds that possess a melting temperature below 100 °C. Their physical and chemical properties are attractive for various applications. Several organic materials that are now classified as ionic liquids were described as far back as the mid‐19th century.
Ferraz, Ricardo, Branco, Luís C., Prudêncio, Cristina, Noronha, João Paulo, Petrovski, Željko   +4 more
openaire   +3 more sources

STABILITY-INDICATING LC METHOD FOR THE QUANTIFICATION OF MIDAZOLAM ACTIVE PHARMACEUTICAL INGREDIENT AND IN PHARMACEUTICAL FORMULATIONS

Drug Analytical Research, 2018
A stability-indicating LC method was validated for the quantification of midazolam (MDZ) active pharmaceutical ingredient (API) and in pharmaceutical formulations. Isocratic chromatography was performed on C18 column with mobile phase containing methanol/
Daiane Anzilaggo, Bádila Regina Dalla Costa, Luciana Grazziotin Rossato-Grando, Hellen Karine Stulzer, Charise Dallazem Bertol   +4 more
doaj   +9 more sources

Enhanced Dissolution of Naproxen by Combining Cocrystallization and Eutectic Formation

Pharmaceutics, 2021
Improving dissolution properties of active pharmaceutical ingredients (APIs) is a critical step in drug development with the increasing occurrence of sparingly soluble APIs.
Hakyeong Kim, Soeun Jang, Il Won Kim
doaj   +1 more source

Results for active pharmaceutical ingredient, pH and retention status.

, 2021
Results for active pharmaceutical ingredient, pH and retention status.
Joyce M. Ondicho (11467141), Lucia K. Keter (11467144), Lilian C. Koech (11467138), Beatrice Njeri Irungu (11467135)   +3 more
core   +1 more source

(1R,3S)-3-(1H-Benzo[d]imidazol-2-yl)-1,2,2-trimethylcyclopentane-1-carboxylic acid as a new anti-diabetic active pharmaceutical ingredient

Acta Crystallographica Section E: Crystallographic Communications, 2020
The chiral title compound, C16H20N2O2, which can be used for producing active pharmaceutical ingredients for treatment of type 2 pancreatic diabetes and other pathologies dependent on insulin resistance, was prepared from (1R,3S)-camphoric acid and o ...
Sergiy M. Kovalenko, Irina S. Konovalova, Sergiy I. Merzlikin, Vladimir P. Chuev, Dmitry V. Kravchenko   +4 more
doaj   +1 more source

Brazilian national production of active pharmaceutical ingredients: regulatory and strategic framework

Anais da Academia Brasileira de Ciências, 2023
Active Pharmaceutical Ingredient (API) is any component of the final pharmaceutical product that serves as the active ingredient. The goal of the API Manufacturing is to produce APIs that are competitively priced and meet the quality standards with the ...
MARLON DANIEL L. TONINI, RAQUEL O. LOPES, MARIA LETÍCIA C. BARBOSA   +2 more
doaj   +1 more source

Results for samples with intra-batch variation: Active pharmaceutical ingredient, pH and retention status.

, 2021
Results for samples with intra-batch variation: Active pharmaceutical ingredient, pH and retention status.
Joyce M. Ondicho (11467141), Lucia K. Keter (11467144), Lilian C. Koech (11467138), Beatrice Njeri Irungu (11467135)   +3 more
core   +1 more source